
Salvia raises $60m to advance chronic migraine neuromodulation therapy
Salvia BioElectronics has raised €53m ($60m) in a Series B funding round towards advancing its non-invasive approach to treating chronic migraine. The Dutch startup’s MySalvia therapy for individuals with chronic migraine uses implants that target key …